2Kakar S,Muir T,Murphy LM, et al.Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma[J].Am J Clin Pathol,2003,119(3):361-366.
3Zimmerman RL,Burke MA,Young NA,et al.Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver[J].Cancer,2001,93(4):288-291.
4Chu PG,Ishizawa S,Wu E, et al.Hepatocyte antigen as a marker of hepatocellular carcinoma:an immunohistochemical comparison to carcinoembryonic antigen,CD10,and alpha-fetoprotein[J].Am J Surg Pathol,2002,26(8):978-988.
5Ohmori S,Shiraki K,Sugimoto K, et al.High expression of CD34 positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases[J].Hum Pathol,2001,32(12):1363-1370.
6Tsuji M,Kashihara T,Terada N, et al.An immunohistochemical study of hepaticatypical adenomatous hyperplasia,hepatocellular carcinoma and cholangiocarcinoma with alpha-fetoprotein,carcinoembryonic antigen,CA 19-9,epithelial membrane antigen, and cytokerati
7Shimonishi T,Miyazaki K,Nakanuma Y.Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver[J].Histopathology,2000,37(1):55-63.
8Leong AS, Sormunen RT,Tsui WM, et al.Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma,combined tumous and metastatic carcinoma[J].Histopathology,1998,33(4):318-324.
9Fasano M, Theise ND,Nalesnik M, et al.Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific-marker,hepatocyte paraffin 1,and the polyclonal anti-carcinoembryonic antigen[J].Mod Pathol,1998,11(10):934-938.
10Lamps LW,Folpe AL.The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors:a review[J].Adv Anat Pathol,2003,10(1):39-43.
3Wudel LJ Jr,Chapman WC.Indications and limitations of liver transplantation for hepatocellular carcinoma.Surg Oncol Clin N Am 2003;12:77-90,ix.
4Soresi M,Magliarisi C,Campagna P,Leto G,Bonfissuto G,Riili A,Carroccio A,Sesti R,Tripi S,Montalto G.Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.Anticancer Res 2003;23:1747-1753.
5Wennerberg AE,Nalesnik MA,Coleman WB.Hepatocyte paraffin 1:a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.Am J Pathol 1993;143:1050-1054.
6Chu PG,Ishizawa S,Wu E,Weiss LM.Hepatocyte antigen as a marker of hepatocellular carcinoma:animmunohistochemical comparison to carcinoembryonic antigen,CD10,and alpha-fetoprotein.Am J Surg Pathol 2002;26:978-988.
7Sutcliffe R,Maguire D,Murphy P,Portmann B,Rela M,O'Sullivan G,Mufti G,Heaton N.Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma.Transplantation 2005;80:88-94.
10Minervini MI,Demetris AJ,Lee RG,Carr BI,Madariaga J,Nalesnik MA.Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors.Mod Pathol 1997;10:686-692.
